One or multiple immunoglobulins with the capability of binding to specific antigenic determinants intended to be used for the qualitative and/or quantitative detection of PELP1 (proline-, glutamic acid-, leucine-rich protein 1), also known as HMX3 protein, in a clinical specimen.